• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

melanoma

Merck ESMO 2026
Biotech

ESMO: Merck exec unruffled by ‘unfortunate’ cancer vax data leak

Merck & Co.'s Shweta Jain told Fierce about her attitude to the high-profile data leak: “It is what it is.”
James Waldron Oct 24, 2026 6:24am
Merck

ESMO: Merck and Moderna post phase 3 cancer vaccine data early

Oct 22, 2026 4:45pm
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Pfizer offloads scrapped Seagen ADC to Medicus Pharma

Sep 3, 2026 11:31am
Moderna ESMO

Merck-Moderna vaccine data spur talk of Keytruda-like impact

Aug 20, 2026 9:25am
Moderna booth at AACR 2026

Merck-Moderna cancer vax slows recurrence in ph. 3 trial

Aug 19, 2026 6:45am
Melanoma skin cancer

Labcorp nabs FDA green light for BRAF melanoma diagnostic

Aug 10, 2026 9:28am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings